Cogent Biosciences (COGT) Short Interest Ratio & Short Volume $10.98 +0.08 (+0.73%) (As of 09/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cogent Biosciences Short Interest DataCogent Biosciences (COGT) has a short interest of 10.25 million shares. This marks a 0.20% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.1, indicating that it would take 10.1 days of the average trading volume of 1.50 million shares to cover all short positions.Current Short Interest10,250,000 sharesPrevious Short Interest10,230,000 sharesChange Vs. Previous Month+0.20%Dollar Volume Sold Short$110.09 millionShort Interest Ratio10.1 Days to CoverLast Record DateAugust 31, 2024Outstanding Shares109,450,000 sharesPercentage of Shares Shorted9.37%Today's Trading Volume2,585,628 sharesAverage Trading Volume1,495,240 sharesToday's Volume Vs. Average173% Short Selling Cogent Biosciences? Sign up to receive the latest short interest report for Cogent Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCOGT Short Interest Over TimeCOGT Days to Cover Over TimeCOGT Percentage of Float Shorted Over Time Ad Behind the Markets“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Cogent Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/202410,250,000 shares $110.09 million +0.2%N/A10.1 $10.74 8/15/202410,230,000 shares $89.21 million +1.2%N/A9.3 $8.72 7/31/202410,110,000 shares $95.34 million -2.7%N/A9.3 $9.43 7/15/202410,390,000 shares $96.11 million +7.3%N/A8.5 $9.25 6/30/20249,680,000 shares $81.60 million -32.4%N/A7.3 $8.43 6/15/202414,320,000 shares $120.65 million -0.6%N/A10.4 $8.43 Get the Latest News and Ratings for COGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. 5/31/202414,400,000 shares $115.34 million +7.0%N/A10.3 $8.01 5/15/202413,460,000 shares $103.91 million +11.8%N/A8.7 $7.72 4/30/202412,040,000 shares $78.26 million -3.5%N/A5.8 $6.50 4/15/202412,470,000 shares $81.06 million +15.0%N/A5.9 $6.50 3/31/202410,840,000 shares $72.84 million +12.6%N/A5 $6.72 3/15/20249,630,000 shares $67.89 million +6.2%N/A4.5 $7.05 2/29/20249,070,000 shares $63.49 million +45.4%N/A3.5 $7.00 2/15/20246,240,000 shares $55.41 million +23.8%N/A2.5 $8.88 1/31/20245,040,000 shares $22.33 million -5.6%N/A2.6 $4.43 1/15/20245,340,000 shares $27.02 million -6.3%N/A3 $5.06 12/31/20235,700,000 shares $33.52 million -22.3%N/A3.5 $5.88 12/15/20237,340,000 shares $35.82 million -8.5%N/A4.8 $4.88 11/30/20238,020,000 shares $61.51 million +1.1%N/A6.3 $7.67 11/15/20237,930,000 shares $60.90 million +23.0%N/A9.4 $7.68 10/31/20236,450,000 shares $52.63 million +6.6%N/A8.3 $8.16 10/15/20236,050,000 shares $57.60 million +4.1%N/A8.3 $9.52 9/30/20235,810,000 shares $56.65 million -9.2%N/A8.5 $9.75 9/15/20236,400,000 shares $75.26 million -4.3%N/A9.5 $11.76 8/31/20236,690,000 shares $81.68 million +4.9%N/A9.8 $12.21 8/15/20236,380,000 shares $78.41 million +24.9%N/A8.7 $12.29 7/31/20235,110,000 shares $66.38 million +4.5%N/A6.9 $12.99 7/15/20234,890,000 shares $61.27 million -7.2%N/A7 $12.53 6/30/20235,270,000 shares $62.40 million -0.9%N/A7.2 $11.84 6/15/20235,320,000 shares $67.09 million +14.7%N/A7 $12.61 5/31/20234,640,000 shares $54.47 million +2.9%N/A6.5 $11.74 5/15/20234,510,000 shares $53.67 million -15.1%N/A7 $11.90 4/30/20235,310,000 shares $57.14 million -5.9%N/A8.5 $10.76 4/15/20235,640,000 shares $57.92 million -8.6%N/A9.5 $10.27 3/31/20236,170,000 shares $66.57 million -3.3%N/A10 $10.79 3/15/20236,380,000 shares $77.58 million +15.2%N/A9.9 $12.16 2/28/20235,540,000 shares $73.29 million +9.5%N/A7.8 $13.23 2/15/20235,060,000 shares $69.42 million +1.6%N/A6.8 $13.72 1/31/20234,980,000 shares $75.00 million -16.2%N/A6.5 $15.06 1/15/20235,940,000 shares $77.40 million +1.9%N/A7.5 $13.03Forget Trump and Kamala (Ad)Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here 12/30/20225,830,000 shares $67.39 million +19.7%N/A7.8 $11.56 12/15/20224,870,000 shares $58.25 million -4.7%N/A6.4 $11.96 11/30/20225,110,000 shares $64.28 million +7.1%N/A6.4 $12.58 11/15/20224,770,000 shares $55.86 million +1.9%N/A5.7 $11.71 10/31/20224,680,000 shares $63.88 million -4.9%N/A4.7 $13.65 10/15/20224,920,000 shares $66.96 million -8.9%N/A4.8 $13.61 9/30/20225,400,000 shares $80.57 million +42.5%N/A5.2 $14.92 9/15/20223,790,000 shares $62.27 million +17.7%N/A3.4 $16.43 8/31/20223,220,000 shares $53.10 million -30.6%N/A1 $16.49 8/15/20224,640,000 shares $67.79 million -10.1%N/A1.5 $14.61 7/31/20225,160,000 shares $57.22 million -9.2%N/A1.8 $11.09 7/15/20225,680,000 shares $60.83 million +19.3%N/A2 $10.71 6/30/20224,760,000 shares $42.94 million +9.7%N/A1.7 $9.02 6/15/20224,340,000 shares $36.20 million +99.1%11.9%1.6 $8.34 5/31/20222,180,000 shares $10.05 million +6.9%6.0%6.4 $4.61 5/15/20222,040,000 shares $8.28 million +13.3%5.6%6.4 $4.06 4/30/20221,800,000 shares $11.56 million +20.8%4.8%6.4 $6.42 4/15/20221,490,000 shares $13.02 million -13.9%4.0%6 $8.74 3/31/20221,730,000 shares $12.96 million -7.0%4.6%7.9 $7.49 3/15/20221,860,000 shares $10.30 million +12.1%5.1%11.4 $5.54 2/28/20221,660,000 shares $9.84 million +4.4%5.2%10.2 $5.93 2/15/20221,590,000 shares $11.00 million +9.7%5.0%9.1 $6.92 1/31/20221,450,000 shares $10.96 million +4.3%4.2%5.1 $7.56 1/15/20221,390,000 shares $11.30 million +2.2%4.1%4.7 $8.13 12/31/20211,360,000 shares $11.67 million -2.2%4.0%4.6 $8.58 12/15/20211,390,000 shares $11.50 million +28.7%4.1%4.8 $8.27 11/30/20211,080,000 shares $8.55 million -23.4%3.2%3.7 $7.92 11/15/20211,410,000 shares $14.55 million -20.8%4.1%5 $10.32 10/29/20211,780,000 shares $15.09 million -6.8%5.2%9.3 $8.48 10/15/20211,910,000 shares $17.65 million -9.5%5.6%12.2 $9.24 9/30/20212,110,000 shares $17.75 million -4.1%6.2%12.5 $8.41 9/15/20212,200,000 shares $17.95 million +2.8%6.4%8.7 $8.16 8/31/20212,140,000 shares $17.72 million +0.5%6.2%7 $8.28 8/13/20212,130,000 shares $16.83 million +4.4%6.2%7.2 $7.90 7/30/20212,040,000 shares $12.24 million -1.0%5.8%7.1 $6.00 7/15/20212,060,000 shares $13.95 million +4.6%5.9%6.6 $6.77 6/30/20211,970,000 shares $15.98 million +34.0%5.6%5.9 $8.11 6/15/20211,470,000 shares $13.32 million -0.7%4.2%5.5 $9.06 5/28/20211,480,000 shares $12.82 million -4.5%4.2%5.5 $8.66 5/14/20211,550,000 shares $12.32 million -34.9%4.4%4.7 $7.95 4/30/20212,380,000 shares $20.44 million +0.4%6.9%6.5 $8.59 4/15/20212,370,000 shares $20.93 million -16.0%7.1%5.8 $8.83 3/31/20212,820,000 shares $23.52 million +8.9%8.5%6.9 $8.34 3/15/20212,590,000 shares $21.19 million +19.4%7.4%5.7 $8.18 2/26/20212,170,000 shares $17.79 million +42.8%3.8%4.6 $8.20 2/12/20211,520,000 shares $15.05 million +54.0%2.6%3.1 $9.90 1/29/2021987,300 shares $8.97 million +31.6%3.9%2.2 $9.09 1/15/2021750,000 shares $8.93 million No Change1.5%1.8 $11.90 COGT Short Interest - Frequently Asked Questions What is Cogent Biosciences' current short interest? Short interest is the volume of Cogent Biosciences shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 10,250,000 shares of COGT short. Learn More on Cogent Biosciences' current short interest. What is a good short interest ratio for Cogent Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COGT shares currently have a short interest ratio of 10.0. Learn More on Cogent Biosciences's short interest ratio. Which institutional investors are shorting Cogent Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cogent Biosciences: Millennium Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cogent Biosciences' short interest increasing or decreasing? Cogent Biosciences saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 10,250,000 shares, an increase of 0.2% from the previous total of 10,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cogent Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cogent Biosciences: Enlivex Therapeutics Ltd. (0.45%), Aytu BioPharma, Inc. (5.62%), TG Therapeutics, Inc. (21.39%), Biohaven Ltd. (11.56%), MoonLake Immunotherapeutics (15.13%), Rhythm Pharmaceuticals, Inc. (15.77%), Xenon Pharmaceuticals Inc. (4.71%), Dyne Therapeutics, Inc. (7.86%), Merus (11.30%), Iovance Biotherapeutics, Inc. (23.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks. What does it mean to sell short Cogent Biosciences stock? Short selling COGT is an investing strategy that aims to generate trading profit from Cogent Biosciences as its price is falling. COGT shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cogent Biosciences? A short squeeze for Cogent Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COGT, which in turn drives the price of the stock up even further. How often is Cogent Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COGT, twice per month. The most recent reporting period available is August, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ENLV Short Squeeze AYTU Short Squeeze TGTX Short Squeeze BHVN Short Squeeze MLTX Short Squeeze RYTM Short Squeeze XENE Short Squeeze DYN Short Squeeze MRUS Short Squeeze IOVA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COGT) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.